Biomarkers Associated with Organ-Specific Involvement in Juvenile Systemic Lupus Erythematosus
James Greenan-Barrett(Arthritis UK), Coziana Ciurtin(University College Hospital), Nataliya Gak(University College London Hospitals NHS Foundation Trust), Elizabeth C. Rosser(University College of Osteopathy), Devina Shah(Arthritis UK), Michael S. Zandi(MRC Prion Unit), George Robinson(Arthritis UK), Elizabeth C. Jury(University College London), Nina de Gruijter(Arthritis UK), Varvara Choida(Arthritis UK), Maria Leandro(University College Hospital), Ruth J. Pepper(University College Hospital), Simrun Virdee(The Royal Free Hospital), Alan D. Salama(The Royal Free Hospital), Muthana Al-Obaidi(Great Ormond Street Hospital), Georgia Doolan(Arthritis UK)
Cited by 25
Related Papers
Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study
|The Lancet Psychiatry|2020|1.3k
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings
|Brain|2020|1.2k
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids
|Annals of the Rheumatic Diseases|2013|454
Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion
|Annals of the Rheumatic Diseases|2002|342
Heterozygous missense mutations in SMARCA2 cause Nicolaides-Baraitser syndrome
|Nature Genetics|2012|244